| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.8M | — |
| R&D Expense | $338.9M | +42.3% |
| SG&A Expense | $95.3M | +56.0% |
| Operating Income | -$363.4M | -21.5% |
| Income Tax | $0 | — |
| Net Income | -$342.6M | -26.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $894.2M | +21.1% |
| Total Assets | $899.4M | +21.1% |
| Current Liabilities | $70.7M | +47.7% |
| Total Liabilities | $177.3M | +150.5% |
| Stockholders' Equity | $722.2M | +7.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$276.4M | -19.0% |
| Capital Expenditures | $495K | -3.1% |
| Investing Cash Flow | -$37.6M | +83.6% |
| Financing Cash Flow | $426.7M | -6.8% |
| Free Cash Flow | -$276.9M | -18.9% |